The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ALEXION PHARMACEUTICALS INC | COM | 015351109 | 34,998 | 228,882 | SH | SOLE | 228,882 | 0 | 0 | ||
ALTISOURCE ASSET MGMT CORP | COM | 02153X108 | 742 | 39,059 | SH | SOLE | 39,059 | 0 | 0 | ||
APHRIA INC | COM | 03765K104 | 3,472 | 189,019 | SH | SOLE | 189,019 | 0 | 0 | ||
AVANTI ACQUISITION CORP | SHS CL A | G0682V109 | 98 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
CHP MERGER CORP | COM CL A | 12558Y106 | 116 | 11,708 | SH | SOLE | 11,708 | 0 | 0 | ||
COHN ROBBINS HOLDINGS CORP | COM CL A | G23726105 | 98 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
FOLEY TRASIMENE ACQUISTN COR | COM CL A | 34431F104 | 1,871 | 186,352 | SH | SOLE | 186,352 | 0 | 0 | ||
FOLEY TRASIMENE ACQUISTN COR | *W EXP 05/26/202 | 34431F112 | 408 | 255,060 | SH | SOLE | 255,060 | 0 | 0 | ||
GRACE W R & CO DEL NEW | COM | 38388F108 | 972 | 16,240 | SH | SOLE | 16,240 | 0 | 0 | ||
GW PHARMACEUTICALS PLC | ADS | 36197T103 | 8,576 | 39,541 | SH | SOLE | 39,541 | 0 | 0 | ||
INPHI CORP | COM | 45772F107 | 12,039 | 67,479 | SH | SOLE | 67,479 | 0 | 0 | ||
KANSAS CITY SOUTHERN | COM NEW | 485170302 | 1,810 | 6,860 | SH | SOLE | 6,860 | 0 | 0 | ||
MARVELL TECHNOLOGY GROUP LTD | ORD | G5876H105 | 656 | 13,400 | SH | SOLE | 13,400 | 0 | 0 | ||
REALPAGE INC | COM | 75606N109 | 31,588 | 362,253 | SH | SOLE | 362,253 | 0 | 0 | ||
SCION TECH GROWTH I | UNIT 12/17/2025 | G31067120 | 110 | 10,899 | SH | SOLE | 10,899 | 0 | 0 | ||
SLACK TECHNOLOGIES INC | COM CL A | 83088V102 | 55,902 | 1,375,868 | SH | SOLE | 1,375,868 | 0 | 0 | ||
SUPERNOVA PARTNERS ACQUISITI | COM CL A | 86846V108 | 303 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
TG THERAPEUTICS INC | COM | 88322Q108 | 844 | 17,500 | SH | SOLE | 17,500 | 0 | 0 | ||
XILINX INC | COM | 983919101 | 1,207 | 9,742 | SH | SOLE | 9,742 | 0 | 0 |